Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about ER STRESS: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No summary available yet. View on Wiki →
No AI portrait yet
| Name | ER STRESS |
| Key Genes/Proteins | APOE |
| Related Diseases | APOPTOSIS |
| Related Pathways | AUTOPHAGY PATHWAY |
Knowledge base pages for this entity
graph TD
ER_STRESS["ER STRESS"] -->|"regulates"| CLDN5["CLDN5"]
style CLDN5 fill:#1a2a3a,stroke:#4fc3f7,stroke-width:1px,color:#fff
ER_STRESS["ER STRESS"] -.->|"inhibits"| BLOOD_BRAIN_BARRIER["BLOOD-BRAIN BARRIER"]
style BLOOD_BRAIN_BARRIER fill:#1a2a3a,stroke:#4fc3f7,stroke-width:1px,color:#fff
ER_STRESS["ER STRESS"] -->|"mediates"| IL6["IL6"]
style IL6 fill:#1a2a3a,stroke:#4fc3f7,stroke-width:1px,color:#fff
ER_STRESS["ER STRESS"] -->|"associated"| TUMOR["TUMOR"]
style TUMOR fill:#1a2a3a,stroke:#ef5350,stroke-width:1px,color:#fff
ER_STRESS["ER STRESS"] -->|"activates"| UPR["UPR"]
style UPR fill:#1a2a3a,stroke:#4fc3f7,stroke-width:1px,color:#fff
ER_STRESS["ER STRESS"] -->|"regulates"| MTOR["MTOR"]
style MTOR fill:#1a2a3a,stroke:#ce93d8,stroke-width:1px,color:#fff
ER_STRESS["ER STRESS"] -->|"accumulates in"| MACROPHAGE["MACROPHAGE"]
style MACROPHAGE fill:#1a2a3a,stroke:#4fc3f7,stroke-width:1px,color:#fff
DTG["DTG"] -->|"activates"| ER_STRESS["ER STRESS"]
style DTG fill:#1a2a3a,stroke:#4fc3f7,stroke-width:1px,color:#fff
EMP1["EMP1"] -.->|"inhibits"| ER_STRESS["ER STRESS"]
style EMP1 fill:#1a2a3a,stroke:#4fc3f7,stroke-width:1px,color:#fff
HSPA5["HSPA5"] -->|"mediates"| ER_STRESS["ER STRESS"]
style HSPA5 fill:#1a2a3a,stroke:#4fc3f7,stroke-width:1px,color:#fff
AMYOTROPHIC_LATERAL_SCLEROSIS["AMYOTROPHIC LATERAL SCLEROSIS"] -->|"causes"| ER_STRESS["ER STRESS"]
style AMYOTROPHIC_LATERAL_SCLEROSIS fill:#1a2a3a,stroke:#ef5350,stroke-width:1px,color:#fff
DEPRESSION["DEPRESSION"] -->|"interacts"| ER_STRESS["ER STRESS"]
style DEPRESSION fill:#1a2a3a,stroke:#ef5350,stroke-width:1px,color:#fff
style ER_STRESS fill:#5d4400,stroke:#4fc3f7,stroke-width:2px,color:#e0e0e0,font-weight:bold| Target | Relation | Type | Str |
|---|---|---|---|
| Unfolded Protein Response | activates | pathway | 0.95 |
| neuronal death | promotes | process | 0.91 |
| unfolded protein response | activates | process | 0.90 |
| BLOOD-BRAIN BARRIER | inhibits | entity | 0.90 |
| CLDN5 | downregulates | entity | 0.90 |
| cell death | causes | phenotype | 0.90 |
| Neuronal Apoptosis | contributes_to | process | 0.90 |
| Neurodegeneration | contributes_to | disease | 0.90 |
| IL6 | mediates | entity | 0.85 |
| Mitochondrial Damage | causes | process | 0.85 |
| GPR37 Dysfunction | contributes_to | mechanism | 0.85 |
| neurodegeneration | promotes | process | 0.85 |
| Autophagy | upregulates | process | 0.80 |
| SREBP2 | activates | gene | 0.80 |
| Autoinflammatory syndrome | contributes_to | disease | 0.80 |
| Neuronal Vulnerability | contributes_to | phenotype | 0.80 |
| Autophagy Dysfunction | contributes_to | process | 0.75 |
| Synaptic Function | associated_with | process | 0.75 |
| demyelination | causes | phenotype | 0.70 |
| CELL DEATH | activates | phenotype | 0.70 |
| Insulin Resistance | causes | phenotype | 0.70 |
| UPR | activates | entity | 0.70 |
| NECROPTOSIS | activates | phenotype | 0.65 |
| MICROGLIA | protects_against | cell_type | 0.65 |
| AUTOPHAGY PATHWAY | causes | pathway | 0.65 |
| NEURODEGENERATION | causes | disease | 0.65 |
| SYNAPTIC LOSS | protects_against | phenotype | 0.65 |
| CYTOKINES | treats | phenotype | 0.65 |
| Phagocytosis | interacts_with | pathway | 0.55 |
| Unfolded Protein Response | interacts_with | pathway | 0.55 |
| Blood-Brain Barrier | interacts_with | pathway | 0.55 |
| Mtor | interacts_with | pathway | 0.55 |
| Autophagy | interacts_with | pathway | 0.55 |
| WHITE MATTER | expressed_in | brain_region | 0.55 |
| APOPTOSIS | implicated_in | phenotype | 0.55 |
| Immune Response | interacts_with | pathway | 0.55 |
| Glycolysis | interacts_with | pathway | 0.55 |
| Akt | interacts_with | pathway | 0.55 |
| HIPPOCAMPUS | expressed_in | brain_region | 0.55 |
| Lysosomal Degradation | interacts_with | pathway | 0.55 |
| Apoptosis | interacts_with | pathway | 0.55 |
| Oxidative Stress | interacts_with | pathway | 0.55 |
| Sphingolipid | interacts_with | pathway | 0.55 |
| Lipid Metabolism | interacts_with | pathway | 0.55 |
| OPTN | co_discussed | entity | 0.50 |
| Neuron | associated_with | cell_type | 0.50 |
| MACROPHAGE | co_discussed | entity | 0.50 |
| MACROPHAGES | co_discussed | entity | 0.50 |
| UNFOLDED PROTEIN RESPONSE | co_discussed | entity | 0.50 |
| HIPPOCAMPUS | co_discussed | entity | 0.50 |
| Source | Relation | Type | Str |
|---|---|---|---|
| APOPTOSIS | activates | gene | 1.00 |
| AUTOPHAGY | activates | gene | 1.00 |
| CANCER | activates | gene | 1.00 |
| Als | activates | disease | 1.00 |
| Tumor | activates | disease | 1.00 |
| Cancer | activates | disease | 1.00 |
| AUTOPHAGY | associated_with | gene | 1.00 |
| NEURODEGENERATION | activates | gene | 1.00 |
| Inflammation | activates | disease | 1.00 |
| Neurodegeneration | activates | disease | 1.00 |
| ROS | activates | gene | 1.00 |
| DTG | activates | entity | 0.95 |
| Gaucher disease | causes | disease | 0.93 |
| HSPA5 | mediates | entity | 0.90 |
| EMP1 | inhibits | entity | 0.90 |
| BiP | biomarker_for | protein | 0.90 |
| BAX | activates | gene | 0.90 |
| BCL-2 | activates | gene | 0.90 |
| CANCER | therapeutic_target | gene | 0.90 |
| AMPK | activates | gene | 0.90 |
| NEUROINFLAMMATION | activates | gene | 0.90 |
| Als | regulates | disease | 0.90 |
| OXIDATIVE STRESS | activates | gene | 0.90 |
| Tumor | inhibits | disease | 0.90 |
| CANCER | inhibits | gene | 0.90 |
| Als | therapeutic_target | disease | 0.90 |
| COPA Mutations | associated_with | mechanism | 0.85 |
| VceC | causes | protein | 0.85 |
| COPA mutations | activates | mechanism | 0.85 |
| ER calcium homeostasis impairment | triggers | phenotype | 0.85 |
| Lycorine | suppresses | compound | 0.85 |
| Autophagy Activation | inhibits | process | 0.80 |
| autophagy pathway | mediates | pathway | 0.80 |
| AMPK | activates | gene | 0.80 |
| WDR45 | causes | gene | 0.80 |
| oxidative stress response | mediates | pathway | 0.80 |
| APOE4 | induces | gene | 0.80 |
| Tauroursodeoxycholate | inhibits | drug | 0.80 |
| GLP-1 | suppresses | protein | 0.80 |
| Cancer | therapeutic_target | disease | 0.80 |
| Cancer | inhibits | disease | 0.80 |
| INFLAMMATION | activates | gene | 0.80 |
| P62 | activates | gene | 0.80 |
| Als | inhibits | disease | 0.80 |
| CHOP | activates | gene | 0.80 |
| BIP | activates | gene | 0.80 |
| Carcinoma | activates | disease | 0.80 |
| ATF4 | activates | gene | 0.80 |
| OXIDATIVE STRESS | associated_with | gene | 0.80 |
| NLRP3 | activates | gene | 0.80 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| FUS Mutations Alter Stress Granule Material Properties to Co | 0.613 | neurodegeneration | How do pathological stress granules in n |
| ER Stress Reduction as Adjunctive Therapy to Support Autopha | 0.566 | neurodegeneration | Why does iron chelation therapy worsen o |
Scientific analyses that reference this entity
neuroinflammation | 2026-04-08 | 0 hypotheses
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity